Xie, Liyi

Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer

Liu, X., Bao, X., Hu, M., Chang, H., Jiao, M., Cheng, J., Xie, L., Huang, Q., Li, F., & Li, C.-Y. (2020) · Nature

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 490

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): From bench to bedside

Bao, X., Liang, Y., Chang, H., Cai, T., Feng, B., Gordon, K., Zhu, Y., Shi, H., He, Y., & Xie, L. (2024) · Signal Transduction and Targeted Therapy

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 187

The Expression of AQP5 and UTs in the Sweat Glands of Uremic Patients

Xie, L., Jin, L., Feng, J., & Lv, J. (2017) · BioMed Research International

Ion Transport and Channel RegulationAcute Kidney Injury Research

Cited by 25